CLARIO

Last updated
CLARIO
Company type Private
Industry Healthcare
Clinical Research
Pharmaceutical Service
Medical Technology
Founded1972 (1972)
Headquarters
Philadelphia
,
U.S.
Key people
Christopher Fikry, M.D.(CEO) [1]
Revenue$350 million to $400 million (USD) per year
OwnerPrivately Owned
Number of employees
1001 to 5000 employees (2024)
Website clario.com

CLARIO formerly ERT and Bioclinica [2] is a technology company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. It offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient-reported outcomes (ePRO) in multiple modalities across all phases of clinical research. [3]

History

In 2008 ERT acquired Biosigna, a Munich-based company, which specialized in biomedical signal processing.

In 2009 ERT ended its foray into the electronic data capture (EDC) business as ERT sold its EDC division for approximately $2.025 million of OmniComm shares. [4]

In 2010 ERT acquired the Research Services Division of the CareFusion Corporation. This nearly doubled the company in size and brought a new service line and enhancements to its two current service offerings; Respiratory Services, specializing in centralized spirometry, Multi-Mode ePRO for patient reported outcomes, and enhanced Cardiac Safety Solutions. Along with the acquisition, ERT now has the capability to design and construct their own clinical diagnostic devices from a manufacturing facility in Estenfeld, Germany. [5]

In 2010, the then current CEO of ERT was replaced on an interim basis by Joel Morganroth, M.D. [6] [7] [8]

In 2011 Jeffrey S. Litwin, M.D. was appointed ERT's new president and chief executive officer. Litwin joined ERT in 2000 as senior vice president and chief medical officer and was subsequently promoted in December 2005 to executive vice president and chief medical officer. Dr. Litwin oversaw ERT's global cardiac safety operations for seven years.[ citation needed ]

On July 3, 2012, ERT announced that Genstar Capital LLC of San Francisco acquired ERT in a take-private transaction valued at approximately $400 million.[ citation needed ]

In November 2014 ERT acquired eClinical Insights (eCI), a provider of cloud-based clinical trials management software. [9]

On February 27, 2015, ERT acquired PHT Corporation (PHT). [10]

In March 2016 ERT was acquired by Nordic Capital, a private healthcare investment firm for about $1.8 Billion. [11]

In December 2016 ERT acquired Exco InTouch, a provider of patient engagement, data capture and digital health solutions.

In May 2017 ERT acquired ImageIQ, clinical trial biomedical imaging and analysis company. [12]

In September 2017 ERT acquired Biomedical Systems (BMS), a provider of imaging as well as cardiac safety and respiratory data collection solutions. [13]

In December 2017 ERT acquired iCardiac Technologies, a global provider of centralized cardiac safety, respiratory, and electronic clinical outcome assessment (eCOA) solutions that accelerate clinical research. [14]

In June 2020 ERT acquired APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers. [15]

In December 2020, ERT announced a merger with Bioclinica, a global clinical trial end-point solutions company. Joe Eazor will be the head of the new business.[ citation needed ]

In November 2021, following ERT and Bioclinica merger, the company renames as Clario. [16]

In April 2024, it was announced Clario had acquired the Leuven, Belgium-headquartered AI medical technology company, ArtiQ. [17]

Related Research Articles

<span class="mw-page-title-main">GE HealthCare</span> American multinational medical technology company

GE HealthCare Technologies, Inc. is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 6.7%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, X-ray; ultrasound; cath labs; mammogram; Nuclear Medicine Cameras; and develops health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.

<span class="mw-page-title-main">Labcorp Drug Development</span> Contract research organization

Labcorp Drug Development presently known as Fortrea is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is spin-off from Labcorp, which employs more than 70,000 people worldwide.

Wolters Kluwer N.V. is a Dutch information services company. The company serves legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare markets.

<span class="mw-page-title-main">Motorola Solutions</span> American data communications and telecommunications equipment provider

Motorola Solutions, Inc. is an American video equipment, telecommunications equipment, software, systems and services provider that succeeded Motorola, Inc., following the spinoff of the mobile phone division into Motorola Mobility in 2011. The company is headquartered in Chicago, Illinois.

The Clinical Data Interchange Standards Consortium (CDISC) is a standards developing organization (SDO) dealing with medical research data linked with healthcare,made to enable information system interoperability and to improve medical research and related areas of healthcare. The standards support medical research from protocol through analysis and reporting of results and have been shown to decrease resources needed by 60% overall and 70–90% in the start-up stages when they are implemented at the beginning of the research process. Since December 2016, CDISC standards are mandatory for submission to US FDA.

An electronic data capture (EDC) system is a computerized system designed for the collection of clinical data in electronic format for use mainly in human clinical trials. EDC replaces the traditional paper-based data collection methodology to streamline data collection and expedite the time to market for drugs and medical devices. EDC solutions are widely adopted by pharmaceutical companies and contract research organizations (CRO).

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook and operates the Parexel-Academy.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.

A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadlines and milestones.

Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American healthcare company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. Before a merger with National Health Laboratory in 1995, the company operated under the name Roche BioMedical. Labcorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina, where the company is headquartered. As of 2018, Labcorp processes 2.5 million lab tests weekly.

A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

<span class="mw-page-title-main">PPD, Inc.</span> Global contract research organization

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.

Glenn Laffel is a physician and health IT entrepreneur. He formerly served as the Senior Vice President of Clinical Affairs for Practice Fusion, a San Francisco-based company that offers a Web-based Electronic Health Record (EHR) for free to physicians.

Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. Headquartered in New York City, Medidata has locations in China, Japan, Singapore, South Korea, the United Kingdom, and the United States.

RLDatix is a global enterprise software company offering software and services tailored to healthcare organizations. The technology platform is designed to support hospitals and other providers with risk mitigation, regulatory compliance, and workforce management resources.

Bigfoot Biomedical Inc. is a medical technology start-up headquartered in Milpitas, California, founded by a team of people with personal connections to type 1 and type 2 diabetes.

Biomedical Systems Corporation was a global company specializing in clinical trials services and medical devices to biopharmaceutical and healthcare organizations.

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.

References

  1. ↑ "New Clario CEO, Christopher Fikry, M.D., to lead company through next phase of growth and innovation". 1 July 2022.
  2. ↑ "ERT and Bioclinica become Clario". 3 November 2021.
  3. ↑ "ERT Milestones". Archived from the original on 2010-05-02. Retrieved 2009-11-11.
  4. ↑ Key, Peter (2009-06-24). "OmniComm buys eResearch Technology's data capture unit". American City Business Journals . Archived from the original on 2009-07-15.
  5. ↑ "You searched for 43".
  6. ↑ "ERT | ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO". 21 December 2010.
  7. ↑ "Ringling College receives record-breaking $15 million gift | Arts and Entertainment". 29 January 2018.
  8. ↑ "Ringling College Receives Landmark Gift, Endowment for VR Department Head - SRQ Daily Jan 30, 2018".
  9. ↑ "ERT Announces Acquisition of eClinical Insights". 6 November 2014.
  10. ↑ "ERT Completes Acquisition of PHT Corporation". 11 May 2015.
  11. ↑ "Nordic Capital Fund VIII and Novo A/S announce the closing of the acquisition of ERT | Nordic Capital".
  12. ↑ "ERT Acquires Imaging Solution from Cleveland Clinic". 9 May 2017.
  13. ↑ "ERT Acquires Biomedical Systems". 8 September 2017.
  14. ↑ "ERT Acquires iCardiac Technologies". 4 December 2017.
  15. ↑ "ERT Acquires Wearable Technology Specialist".
  16. ↑ "ERT and Bioclinica become Clario". 3 November 2021.
  17. ↑ Nunwick, Alice (2024-04-03). "Clario acquires ArtiQ AI for clinical trials". Verdict. Retrieved 2024-04-03.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.